DRX reported EPS of $0.34 in Q3, displaying an increase from the prior year of $0.09. Revenue for the quarter came in at $82.1M, displaying year-over-year growth of 21.7% from $65M. Order backlog was solid at $339.3M. Cash from operating activities for the nine-month period ending in Q3 was $45.7M. Adjusted EBITDA was $17.8M growing from $7.5M in the year prior. DRX also announced a ratification of a 5-year collective bargaining agreement by unionized employees at DRX’s Terrebonne plant. Management has stated that it is confident that DRX will be able to continue to grow its backlog and remains active with negotiating numerous projects. This was a strong quarter from DRX and support from a relatively large backlog should help the stock continue its upward momentum into future quarters.
5i Research Answer: